Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Asthma Spacers Market: By Type, By End User, and Region Forecast 2019 - 2030
Asthma Spacers Market: By Type, By End User, and Region Forecast 2019 - 2030
Asthma Spacers Market size was valued at US$ 1.4 billion in 2023 and is expected to grow at a CAGR of 5.5% from 2024 to 2030. Asthma spacers are medical devices used in conjunction with metered-dose inhalers (MDIs) to improve the delivery of asthma medication to the lungs. They consist of a chamber that attaches to the inhaler, allowing the medication to be suspended briefly before inhalation. Spacers offer several advantages, including improved medication delivery, reduced oral deposition of drugs, and easier use for children and elderly patients. They come in various sizes and designs, including mask attachments for younger children.
The market is experiencing growth due to factors such as the increasing prevalence of asthma, growing awareness about proper inhaler techniques, and technological advancements in spacer design. According to the World Health Organization, asthma affected an estimated 262 million people in 2019, and 455,000 fatalities were linked to asthma in the same year, the number is expected to rise. Additionally, the global trend towards self-management of chronic diseases is driving the demand for home-use medical devices like asthma spacers. However, the market faced challenges during the COVID-19 pandemic, with disruptions in supply chains and a temporary decrease in routine asthma management visits. The high cost of some advanced spacers and the lack of awareness in certain regions could potentially hinder market growth.
Study Period
2024– 2030Base Year
2023CAGR
5.5%Largest Market
North AmericaFastest Growing Market
Asia pacific
Asthma spacers are increasingly preferred for managing asthma as they offer several advantages over using metered-dose inhalers alone. These benefits include improved drug delivery to the lungs, reduced oropharyngeal deposition of medication, and easier use for patients with poor hand-breath coordination. Spacers act as a reservoir for the aerosolised medication, allowing patients to inhale at their own pace, which is particularly beneficial for children, elderly patients, and those experiencing acute asthma attacks. The growing emphasis on proper inhaler technique in asthma management guidelines has further boosted the adoption of spacers.
Moreover, the availability of different spacers, including those with masks for infants and young children, caters to diverse patient needs. The increasing focus on reducing emergency room visits and hospitalisations due to asthma exacerbations is also driving the demand for effective home-use devices like spacers. Additionally, ongoing research and development efforts are leading to innovations such as smart spacers with digital interfaces for tracking medication use and technique, which is expected to further propel market growth.
North American asthma spacers market accounted for a significant share. The high prevalence of asthma in the region, coupled with advanced healthcare infrastructure and higher awareness about asthma management, is driving the demand for asthma spacers. Other factors contributing to this growth include stringent air quality regulations, an aging population more susceptible to respiratory conditions, and strong healthcare reimbursement policies.
The Asia-Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing urbanization, rising air pollution levels, growing healthcare expenditure, and improving awareness about asthma management in countries like China and India.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024– 2030 |
|
Market Size in 2023 |
US$ 1.4 billion |
|
Market CAGR |
5.5% |
|
By Type |
|
|
By End User |
|
|
By Region |
MEA |
Download Free Sample Report
The global asthma spacers market size was valued at US$ 1.4 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2030.
North America accounts for the highest rate of growth in the asthma spacers market
The major players in the market include Trudell Medical International, Koninklijke Philips N.V., Cipla Limited, Lupin Limited, Pari GmbH, Respiratory Delivery Systems, Inc., AstraZeneca, GlaxoSmithKline plc, Vortran Medical Technology 1, Inc., and Monaghan Medical Corporation
Key drivers include the increasing prevalence of asthma, growing awareness about proper inhaler technique, technological advancements in spacer design, and a trend towards self-management of chronic diseases.
Restraints include the high cost of some advanced spacers, lack of awareness in certain regions, and potential disruptions in supply chains as observed during the COVID-19 pandemic.
| 1. Executive Summary |
| 2. Global Asthma Spacers Market Introduction |
| 2.1.Global Asthma Spacers Market - Taxonomy |
| 2.2.Global Asthma Spacers Market - Definitions |
| 2.2.1.Type |
| 2.2.2.End User |
| 2.2.3.Region |
| 3. Global Asthma Spacers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Asthma Spacers Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Asthma Spacers Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Aerochamber |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Optichamber |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Volumatic |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Asthma Spacers Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hospitals & Clinics |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Homecare Settings |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Asthma Spacers Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Asthma Spacers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Aerochamber |
| 8.1.2.Optichamber |
| 8.1.3.Volumatic |
| 8.1.4.Others |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals & Clinics |
| 8.2.2.Homecare Settings |
| 8.2.3.Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Asthma Spacers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Aerochamber |
| 9.1.2.Optichamber |
| 9.1.3.Volumatic |
| 9.1.4.Others |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals & Clinics |
| 9.2.2.Homecare Settings |
| 9.2.3.Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10. Asia Pacific (APAC) Asthma Spacers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Aerochamber |
| 10.1.2.Optichamber |
| 10.1.3.Volumatic |
| 10.1.4.Others |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals & Clinics |
| 10.2.2.Homecare Settings |
| 10.2.3.Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Asthma Spacers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Aerochamber |
| 11.1.2.Optichamber |
| 11.1.3.Volumatic |
| 11.1.4.Others |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals & Clinics |
| 11.2.2.Homecare Settings |
| 11.2.3.Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Asthma Spacers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Aerochamber |
| 12.1.2.Optichamber |
| 12.1.3.Volumatic |
| 12.1.4.Others |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals & Clinics |
| 12.2.2.Homecare Settings |
| 12.2.3.Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Trudell Medical International |
| 13.2.2.Koninklijke Philips N.V. |
| 13.2.3.Cipla Limited |
| 13.2.4.Lupin Limited |
| 13.2.5.Pari GmbH |
| 13.2.6.Respiratory Delivery Systems, Inc. |
| 13.2.7.AstraZeneca |
| 13.2.8.GlaxoSmithKline plc |
| 13.2.9.Vortran Medical Technology 1, Inc. |
| 13.2.10.Monaghan Medical Corporation |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.